SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
Sebastian Bauer (MD) underwent his medical training at the University of Würzburg, Germany and his resisdency and medical oncology fellowship at the University of Duisburg-Essen, Germany. He is committed to clinical care, clinical research and translational, lab-based research in sarcomas. He is Professor of Translational Oncology (Personalized Cancer Therapy) at the Dept. of Medical Oncology, University Hospital Essen as well as Director of the Sarcoma Center at the West German Tumor Center, one of the largest sarcoma programs in Europe. Dr Bauer has served as principal investigator in more than 50 clinical trials in bone, soft-tissue sarcomas, including gastrointestinal stromal tumors. His research group is focused on model development, resistance mechanisms to targeted treatments (primarily in GIST) and academic drug development. He is member of the steering committee of the German Sarcoma Study Group (AIO), member of the EORTC (STBSG) and board member of the German Sarcoma Foundation. He has in the past served as ESMO sarcoma track chair and is currently member of the sarcoma sub-committee. He is a regular reviewer for cancer-related journals and sarcoma meetings (CTOS, ESMO).
10 years of independent medical education in GI oncology
Journey through a patient case from testing and diagnosis to treatment and AE management
Looking beyond the obvious mutations in non-small-cell lung cancer
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Maximising outcomes for patients with advanced CRC
Make decisions for your patient at two key stages in their journey